Circle Pharma
PrivateLast Round
Series E
Sep 16, 2026
Total Funding Raised
$300M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Circle Pharma is a biopharmaceutical company that develops cell-permeable macrocyclic peptide therapeutics for the treatment of cancer and other serious illnesses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circle Pharma Comparables
Compare Circle Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unnatural Products | 84% | |
| Dayra Therapeutics | 80% | |
| Parabilis Medicines | 80% | |
Circle Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 16, 2026 | ||||
| Series D | Sep 3, 2024 | ||||
| Series C | Jun 16, 2021 | ||||
| Series B | Mar 17, 2020 | ||||
| Series A | Apr 25, 2017 | ||||
Seed | Jan 7, 2016 |
Key People
Founding team and executive leadership
Circle Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series C, Series E, Series D |
| RA Capital Management | Series E |
| WI Harper Group | Series A |
| Lifeforce Capital | Series B, Series C, Series A |
| The Chernin Group | Series B, Series C |
| Berkeley Catalyst Fund | Series B, Series C |
| Hartford Hospital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
$93M round led by The Column Group
- Jun 18, 2026
Monthly visitors increased 46% MoM.
Circle Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Circle Pharma's valuation, stock price, and market status.